secwatch.observer — SEC 8-K summary
======================================

Issuer:     Parabilis Medicines, Inc. (PBLS)
CIK:        0001657677
Form:       8-K
Filed at:   2026-06-11T20:12:52+00:00
Accession:  0001193125-26-267550
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Regeneron invests $75M in Parabilis at 10% discount to IPO price in concurrent private placement
--------------------------------------------------------------------------------

- Purchased 4,166,666 shares at 90% of $20 IPO price ($18/share); total $75M.
- Private placement closed June 11, 2026, alongside IPO.
- Regeneron granted piggyback registration rights on the shares.
- Charter amended to authorize 600M voting and 200M non-voting common shares, eliminate preferred.
- Transaction signals strategic backing from a major biopharma partner.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1657677/000119312526267550/0001193125-26-267550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1657677/000119312526267550/ck0001657677-20260609.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-267550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer